{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-005405","form_type":"8-K","ticker":"PAYS","cik":"0001496443","company_name":"Paysign, Inc.","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.090719+00:00","generated_at":"2026-06-12T01:39:11.142049+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Paysign Q2 revenue up 28% to $11.0M; Adjusted EBITDA $1.1M; guides FY rev $44-46M","bullets":["Revenue $11.0M, up 28% YoY; net loss $0.1M ($0.00 EPS).","Adjusted EBITDA $1.1M, up 23% YoY; FY 2023 guidance revenue $44-46M, Adj EBITDA $6.0-7.5M.","Added 4 net plasma centers, exit at 443; launched 5 new patient affordability programs, now 31 active.","Pharma patient affordability revenue up 133% to $729K; repurchased 119,558 shares for $312K.","Transitioned 16 mature plasma centers in July, total >460 centers."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-005405","json":"https://secwatch.observer/filing/0001683168-23-005405.json","markdown":"https://secwatch.observer/filing/0001683168-23-005405.md","text":"https://secwatch.observer/filing/0001683168-23-005405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496443/000168316823005405/0001683168-23-005405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496443/000168316823005405/paysign_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T01:39:11.142049+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"102994f96c1f6bf4902ba36c1e32a846a2ae4d53","claim":"Paysign, Inc. reported the fiscal quarter ended June 30, 2023 results: revenue $11.0 million, net income ($0.1) million, EPS ($0.00) per diluted share.","evidence_excerpt":"Paysign, Inc. Reports Second Quarter 2023 Financial Results · Second quarter total revenues of $11.0 million, an increase of 28% compared to second quarter 2022 · Second quarter net loss of ($0.1) million and diluted loss per share of ($0.00)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1496443/000168316823005405/0001683168-23-005405-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter ended June 30, 2023"},{"label":"Revenue","value":"$11.0 million"},{"label":"Net income","value":"($0.1) million"},{"label":"EPS","value":"($0.00) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}